Tracking tuberculosis risk in autoimmune rheumatic disease
Part of Infections clinical trials.
This study is watching people with autoimmune rheumatic diseases to see how many develop tuberculosis over time. It may help researchers understand the risk so they can better protect patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with an autoimmune rheumatic disease (like rheumatoid arthritis or lupus).
- Your TB test (skin or blood) must show no current or past active infection.
- You cannot have any prior history of tuberculosis or treatment for it.
- You need to be able to participate in follow-up for at least 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study follows new college students with a strong reaction to a tuberculosis skin test to see if they develop the disease, and compares them to students without a strong reaction. It tests whether monitoring this group more closely can help catch tuberculosis early.
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
This study follows patients being treated for tuberculosis with standard medications to see how well the treatment works and what side effects occur. Your medical records and check-ups help doctors understand which treatments are most effective.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
Hear when a new Autoimmune Rheumatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.